Special Workshop on ICT in HealthCare Services (e-Health and TeleMedicine)

Chairman: Giuseppe TRITTO (WABT - WEIL) Co-Chairmen – Lodewijk BOS (WABT - ICMCC), Attila VERECZKEY ( Versys Clinics,

Human Reproduction Institute, MHRT-HHRS)

• Compunetics, the Concept preceding Health 2.0 Lodewijk BOS, President ICMCC, Editor-in-Chief Health and Technology, WABT Board Member, Utrecht, The Netherlands

• How to use European Funds for Bilateral and International Cooperation

Roberto MORINILLI, CEO Gaia Italy, Torino, Italy

• Innovation models to transfer knowledge into business Gabor VICZE, Econet Open Funding Kft, Budapest, Hungary

• Real World Developments in providing Education and Training to Doctors Ram DHILLON, RILA Institute of Health Sciences, London, UK

• eHealth Services and Providers Management for High-Specialized Clinical Hubs Network (The Model for Human Reproduction Clinical Hubs) Giuseppe TRITTO, President WABT - ICET, Paris, France – WEIL, Budapest, Hungary

• Introducing Fertility Preservation Methods in Hungary: the Importance of a Central European Network Attila VERECZKEY, Director VERSYS Clinics, Human Reproduction Institute, Vice-President Hungarian Association of Human Reproduction, Budapest, Hungary

• The Italian Screening Programme for Fetal Aneuploidies Pietro CIGNINI, Artemisia Spa, Italian College of Fetal Maternal Medicine, Rome, Italy

• E-Health in Web-Space: Legal Issues (Implementation on Human Reproduction in Global Health Management) Alice KAROUBI NORDON, Ascott Associes Lawyers Firm, WABT-ICET Board Member, Paris, France

Contact point: Galina Sklyarova, WEIL Foundation,

wabteifl@gmail.com galinaweilfoundation@gmail.com

This Seminar includes three parts, the first one is dedicated to the Compunetics implementation on web for Health and Healthcare and to the EU strategies and funds raising on innovation models in knowledge and technology transfer for business partnership. The second part is related to the new efforts of continuous educational post-graduated programs for Health operators and to the design and realization of

specific eHealth Services and Providers for specialized Clinical Hubs. The third part is related to specific models of Health Systems Delivery, principally concerning Human Reproduction and Medical Tourism with mobility of the Operators, of the Clients and of the biological living preserved artefacts, and the Legal Issues.

1.eHealth Services and Providers Management for High-Specialized Clinical Hubs Network (The Model for Human Reproduction Clinical Hubs), In cooperation with Andrew Marsh (HoIP – WABT), Alice Karoubi Nordon (Ascott Associes – WABT) and Galina Sklyarova (WEIL)

Giuseppe TRITTO

Executive President WABT – World Academy of Biomedical Sciences and Technologies

President ICET – International Council for Engineering and Technologies

President WABT European Institute for Life – WEIL Foundation

President International Forum “ Science& Peace” - SPES (for Development and Health)

Biography: Professor Giuseppe TRITTO is Executive President of the WABT – World Academy of BioMedical Sciences and Technologies (c/o INSULA - UNESCO) founded under the aegis of UNESCO in 1997 in Paris and President of the WABIT – World Association of Bio Info Technologies in Lugano, Switzerland. He is Executive President of the ICET – The International Council for Engineering and Technologies, an international umbrella NGO inspired by UNESCO in 1995 in Paris. He launched The International Forum " Science & Peace" - SPES for Development and Health and is leading the Project SPACE for SCIENCE for South Eastern Europe, under the aegis of UNESCO CI/INF/ICT Sector, with worldwide potential extensions.

He has assigned the Award ‘ Premio Guido Dorso’, International Section, in 2012, from the Italian Presidency, as “ Ambasciatore per il Mezzogiorno “ in the world.

He has assigned the “ Life Time Achievement Award “ for his understanding contribution in the area of Genital Reconstructive Surgery and Microsurgery from the India Ritnand Balved Education Foundation from Amity Institutions in New Delhi in 2012.

Professor Giuseppe TRITTO is internationally well known Reconstructive Microsurgeon with specific expertise in Reproductive Surgery and Microsurgery, Genital Reconstructive Surgery and Applied BioEngineering in Micro and Nanotechnologies.

He founded different international Associations related to Andrology and Men’s Health Medicine: IASTA-International Association of Sciences and Technologies for Andrology; ESMGS-European Association of Male Genital Surgery; AF-CGM-Association Francophone de ChirurgieGenitale Male; AEFF – Association pour l’Etude de la Fertilité de la Femme; IASS-

IASA-International Association of Sexual Surgery and Surgical Andrology and the EMAPS-European and Mediterranean Academy of Phalloplasty Surgeons. He is Founder of the World Andrology Society – World Andrology Network (WAS – WAN).

Prof. Giuseppe TRITTO was nominated Professor of Microsurgery and Microtechnologies in Aston University, Birmingham, UK and is actually Deputy Professor at BIB-Brunel Institute for Bioengineering, Brunel University, London, UK. Prof. Giuseppe TRITTO has been assigned in 2012 as Director of the Chair of NanoMedicine at Amity University, Noida, New Delhi, India.

Professor Giuseppe TRITTO is President of the European Institute for Life in Budapest, Hungary, Founder and Medical Director of the CMM-Clinics for Male Microsurgery Network.

Professor Giuseppe TRITTO is promoting his leadership at the scientific, professional and international level as a builder of progress and a builder for life, creating strategic convergences and operational interfaces between (bio) – technology innovation and clinical applications in health and health-care through knowledge and technology transfer international cooperation programs.

Abstract eHealth Services and Providers Management for High-Specialized Clinical Hubs Network

(The Model for Human Reproduction Clinical Hubs)

1,2.Giuseppe TRITTO, 2.Galina SKLYAROVA, 1,3.Alice KAROUBI, 1,4.Andrew MARSH

1.WABT International,Paris, France 2.WEIL Foundation, Budapest, Hungary 3. Ascott-Associes, Paris, France 4. HoIP, London, UK

e-mail contact: GalinaWEILFoundation@gmail.com, wabteifl@gmail.com,

Keywords: W-Space, I-Cloud, Health I-Cloud, eHealth, Human Health Medicine, Medicine of Life

BACKGROUND:Web-Space for Science and Web-Space for Health from WABT and HoIP

WABT – The World Academy of BioMedical Sciences and Technology in 2011 at the WORLDCOMP in Las Vegas, July 18-21, 2011, proposed W-Space for Health as an interface platform, using HoIP (Health over Internet Protocol) e-Services and Providers to offer solutions in developing countries for Global Health Management, with particular attention to collect data for immunization at large scale and to monitor clusters of population at-risk, according UN and World Bank policies and mandates. The Global Strategy proposed by W-Space for Health links the potentialities of the Space and TelecommunicationTechnology solutions with the fast access to the "Cloud" and to the storage of data on the Health conditions of populations through security protocols for international cooperation management, based on the implementation of the capacity building of the pillars of knowledge societies (K-creation, K-preservation, K-dissemination, K-utilization), for Knowledge and Technology Management and Transfer. (KTM) In Public Health Strategy Development and in Inter-Operability Strategies for implementation of dedicated health programs, the strategic Vision, based on 1. market, social, political factors 2. strategic goals and framework 3. major scientific challenges, must interface with the Technology Roadmap, based on 1.Science, Technology, Engineering 2. Critical Activities and R & D Priorities 3. Activities Pathways and Action Plans: the Problem Definition and the Potential Solutions are matched. Web-Space for Health ad hoc Services and Providers can help to

implement Global Strategies on large scale populations, bridging public and private health prevention programs with international cooperative interventions.

HEALTH I - CLOUD

At WOLRDCOMP in Las Vegas, July 16-19, 2012, WABT introduced for the first time the definition and the description of I-Cloud for Health – HI-Cloud. Web-Space for Health (H I-Cloud) represents a new visionary approach 1. to identify, 2. to manage and 3. to implement respectively I. The needs of populations for health services and providers, II. The networks of health and health-care systems widespread in the world, III. The knowledge and technology transfer of biomedical innovations from high income countries towards low income countries at accelerated growth.

The Global Strategy proposed by W-Space for Health, especially in Preventative Medicine, links the potentialities of the Space and TelecommunicationTechnology solutions with the fast access, potentially free, to the "Cloud" and to the storage of health data of populations through security protocols for international cooperation in Global Health Management (GHM).

Global Health Technology and Management

The potentialities to implement Space Technology Strategies linked to the network capabilities of the Cloud at the service of Global Health and Health-Care programs can be explored in fundamental sectors of the Human Population Welfare, as Immunization to protect the large majority of population in any region of the globe, as Human Reproduction Monitoring and Contraception Policies, as in Human Nutrition Sharing Resources and Industrialization, to set parameters in Health Metrics to prevent and to protect not only the populations in state of vulnerability, but also the large majority of healthy people at the base of the fundamentals of Countries Economies.

The WABT ITEHM Strategy

The WABT Academy on the bases on a New Concept of Medicine for Health – Human Health Medicine – is developing the ITEHM Conceptual Framework linking Innovation Technology – Economics – Human Health. On the new BEST (BioEconomy and Sustainable Development) for Health Vision and Scope in Globalization, the creation of Universal Health Bio Services is a Main Goal, based on one side on the foundations of HUBS for TeleMedicine and eHealth and on the other side on Clinical HUBS for Users, Consumers and Personal Health-Care Management. The Configuration of Health HUBS is based on three key sectors: 1. Hub as a Center of Excellence for Health Services Delivery, 2. Hub as a Training Center for Health Operators, 3. Hub as an International KMC-KTC (Knowledge Management Center - Knowledge Technology Transfer Center) Provider.

Clinical Hubs in Network - CENs

Specialized Centers of Excellence jn Network – CENs satisfy the specific needs of the mobility of the Health Operators and the mobility of the Consumers (so-called Medical Tourism) and the implementations of rules and laws, according the policies of the assurance companies and in general of the internazionalized Health Providers.

Medicine of Life

In December 2010, at the WABT General Conference in Budapest, the Platform of Medicine of Life has been proposed through a Founding Chart, the constitution of the International Society of Medicine of Life and the registration of the WABT Institute for Life Foundation.

A Model of HUBS for Reproductive Medicine and Surgery in Medicine of Life.

Reproductive Medicine is a fundamental pillar of the Governments Policies in Family Planning and Welfare, not only in the traditional field of Contraception, but today in Preventative Medicine for Reproduction and Sexually Transmitted Diseases – STDs, for Epigenetic Screening and for BioGenetic Technologies (SynBionics). Reproductive Surgery is a new field of clinical applications in male and female procedures, supported by the intensive implementation of Minimally Invasive Laparoscopic and Surgical Techniques (MIS – Minimally Invasive Surgery) and by MicroSurgery (MIMIS – Micro Minimally Invasive Surgery and MIRS – MicroReconstructive Surgery) using MicroTools, Miniaturized Microsensors and Infrared Microcameras that are dramatically changing the actual practices in the operating theatre and in the Repro-Labs.

The Legal Issues and the availability of Innovative Technologies and Procedures in Medicine of Life generate an incredible pressure to share the Global Knowledge in Human Reproduction Technologies in specialized and dedicated Clinical Networks and to link in an operational chain supported by ICT tools and infrastructures all the HUBS practicing Knowledge Transfer Biotechnologies for Human Applications in Reproductive Medicine and Surgery.

2.Compunetics, the Concept preceding Health 2.0 Lodewijk BOS, President ICMCC, Editor-in-Chief Health and Technology,

WABT Board Member, Utrecht, The Netherlands

Founding President of ICMCC since 2003, editor of the CMCC bookseries, Co-Editor-in-chief of the Health and Technology journal.Regular presenter at international events.Moderator of the ICMCC News and Science website pages.Cancer survivor.

ICMCC

The International Council on Medical & Care Compunetics

Using knowledge to create knowledge is the major concept of the emerging knowledge society. This way, knowledge becomes sustainable and a tool to realize the millennium goals. But to achieve this in the most effective way, we will have to make inventories of knowledge.

ICMCC (International Council on Medical & Care Compunetics) is an international foundation operating as the knowledge centre for medical and care compunetics (COMPUting & Networking, its EThICs and Social/societal implications), making information on medicine and care available to patients using compunetics as well as distributing information on the use of compunetics in medicine and care to patients and professionals.

Knowledge is derived from the synthesis between information and experience. ICMCC is becoming the global guiding platform in bringing information and experience related to medical and care compunetics together, thus creating the necessary inventories of knowledge. As we are aiming at both the patient/citizen and the professional we also target and facilitate the shifting relationship between the two.

Abstract “Compunetics, the concept preceding Health 2.0”

This presentation will deal with the definitions of compunetics and Health 2.0.

It will cover the need for and essence of ICT related issues in medicine and care, more specific with the patient-related aspects in mind e.g. medical records, mhealth.

Awareness and the importance of information dissemination will also be covered.

3.e-Health in Web-Space: Legal Issues (Implementation on Human Reproduction in Global Health Management)

Alice KARUBI-NORDON

Avocat à la Cour Founding Partner of Ascott-Associés

Board Member WABT-ICET (WWO Network), Paris, France

Biography: Beginning her career in the legal department of the multinational Plantronics (Santa Cruz California – 2000), Alice worked at the International Court of Justice of The Hague. She joined Richards Butler in 2001, established a Spanish desk in Madrid (2004). She is a founding partner of the law firmAscott-Associés in 2007.

She graduated from the University of La Sorbonne, hold an advanced degree in international business law as well as an advanced degree in international trade law. She has been appointed as mediator and arbitrator of the French and Spanish Chamber of Commerce in Paris.

Practice areas:

• Economic Law - Dealing with French, European and international regulatory Authorities

• Corporate Law -Mergers and Acquisitions - Corporate Restructurings

• Commercial Law and Trade Agreements (franchise and distribution agreements)

• European Law and Competition Law

• New Technologies and Media Law

Notable work:

• Advising several international industrial groups for their mergers, acquisitions and restructurings (Ineos / Conagra / McBride / Geest…)

• Advising new technologies, multimedia group, call center and television channel

• Advising international groups for their dealings with the administrative services and national regulatory authorities

Abstract Cross-border activities in health care in the world wide, or specially the European or American single market are increasing. Many of these cross-border developments are related to e-Health.

e-Health describes the application of information and communication technologies across the whole range of functions that affect the health care sector e-Health is a new vision of Health as a fundamental asset of the new economies in developing and at low-income countries. Telemedicine systems are now operating between the hospitals, between the hospitals and the private specialists and even between the

private specialists. This new technology creates a new situation where two or more specialists decide on a diagnosis, together, and at the same time, but in different geographical locationsi. Interoperability is a key word to be applied on the E-Health to develop the interfaces to connect and sharing data, integrated information and to sustain the operational networks. After listing the main good aspects of E-Health (I), it would be presented its barriers (II) and the regulation who tries to support it development (III).

4. Introducing Fertility Preservation Methods in Hungary The Importance of a Central European Network

Attila Vereczkey, Ibolya Czegle, Éva Margittai, Éva Csajbók, Sándor Sávay, Zsolt Kósa

Versys Clinics, Human Reproduction Institute, Budapest, Hungary

Attila VERECZKEY

Director VERSYS Clinics, President Human Reproduction Institute, Vice- President Hungarian Association of Human Reproduction, Budapest, Hungary

BIOGRAPHY

Attila Vereczkey M.D,M.A.

I graduated in 1990 at the Albert Szent-Györgyi Medical University, Hungary. I acquired my second qualification at Attila József University, Faculty of Economics and Finance in 1996, Hungary. My third degree is from the Budapest University of Economic Sciences, where I have studied International and Diplomatic Studies and got my degree in International Diplomacy in 1999, Hungary.

I made my OB/GYN specialization at the Albert Szent-Györgyi Medical University, Dept. of Obstetrics and Gynecology, WHO Collaborating Research Centre on Human Reproduction.

I made the European Exam for Excellency in Obstetrics and Gynaecology in 1995.

During my professional career, I had been the Medical Director of an international pharmaceutical company and I was working at the Semmelweis Medical University, dept. of OB/GYN. Later I was appointed to be the Medical Director of the Nyírő Gyula General Hospital, Department of Infertility, and Assisted Reproductive Techniques, Reproductive Endoscopic Surgery.

I have founded Reprogenex, Microarray CGH, molecular genetic diagnostic laboratory, which firstly introduced the preimplantation genetic diagnostics and screening (PGD/PGS) with aCGH in Hungary.

In 2010 I founded Versys Clinics, Human Reproduction Institute where I am presently working as a Medical Director.

I was trained and collected my knowledge and skills in several famous medical clinics all over the world, e.g.: UK; Finland; Austria; USA; Germany, Italy etc.

I am also a member of many international scientific societies and I am the Vice President of the Hungarian Human Reproduction Society.

I am the author and co-author of several publications, book chapters and scientific publications.

Abstract

Attila Vereczkey, Ibolya Czegle, Éva Margittai, Éva Csajbók, Sándor Sávay, Zsolt Kósa

Versys Clinics, Human Reproduction Institute, Budapest, Hungary

The definition of fertility preservation includes all the techniques serve to preserve ovarian function after gonadotoxic therapy. Due to improvements in cancer therapy, cure rates of cancers increased significantly over the past decades, which – together with the continuously rising maternal age at first birth – give special importance for the techniques serve to protect fertility.

The preservation of fertility is usually mentioned in malignant cases, since malignancies respond well to radiotherapy or chemotherapeutical agents, which both often have deleterious effects on the gonads. Important to emphasize though that other diseases exist which are only curable with chemotherapy. Cyclophosphamide, a highly gonadotoxic agent is often used to alleviate the exacerbation period of autoimmune diseases. Since the occurrence of these benign syndromes has a peak at younger age, these patients might profit from fertility preservation techniques, too.

Several options exist to preserve reproductive functions of patients undergoing cytotoxic therapy. Gonadotropin-releasing hormone (GnRH) analogues in parallel with cyclophosphamide treatment were described to have a protective effect for the ovaries. After the stimulation of ovaries, the cryopreservation of unfertilized or fertilized oocytes is also possible. The newest strategy involves the excision of a slice from the ovarian cortex before the gonadotoxic treatment followed by its cryopreservation, and after the patient’s complete recovery, its autotransplantation. The selection of the optimal preservation technology must always be based on an individual decision, weighing advantages and disadvantages in each technique to be used.

The application of the above mentioned methods is not restricted to patients suffering from malignancies; increasing number of studies describe the need to widen the indication list and depict the safe use of the enumerated fertility preservation techniques in benign diseases as well.

Different fertility preservation methods are used worldwide with an increasing success. There are some countries like Germany, Austria, Switzerland, which formed a Ferti Protect network to provide information and collaborate in the field of oncofertility. The importance of international network is significant, also in the region of Central- Europe, the cooperation with medical centres in oncofertilty is essential.

5. The Italian Screening Programme for Fetal Aneuploidies Pietro CIGNINI, Artemisia Spa, Italian College of Fetal Maternal Medicine, Rome, Italy

Biography

Born in Vetralla, Italy 23/12/1975. After getting the scientific maturity in 1994, graduating in Medicine cum laude in 2000 at University La Sapienza of Rome, discussing the thesis entitled "Fetal Maternal endocrine responses

after administration of betamethasone for fetal lung maturity in pregnancies with threating preterm birth”. During the course of studies has won two awards in the University of Rome "La Sapienza" for the excellent curriculum and obtained a period of residency at the Laboratory of Perinatal Medicine in the same university. During this period conducted study of fetal lung maturity. Contribute to some international studies sponsored by the National Centre of Research (CNR) in Rome about intramniotic surfactant. Conducts numerous experiments in the field of fetal endocrinology with particular attention to fetal endocrine responses to the administration of cortisone for fetal lung maturity in high-risk pregnancies. In 2001, conducted a Master at the University "La Sapienza" of Rome "Doppler and new technologies in Gynecology-Obstetrics and Reproductive Medicine. In 2007 took the specialization in Obstetrics and Gynecology. He is the author of numerous publications in peer- reviewed scientific journals of Maternal-Fetal Medicine. He is "EXECUTIVE EDITOR" of the Journal of Prenatal Medicine (JPM), peer-reviewed journal, indexed in PubMed and other scientific database.

He is in the Editorial Board of the Asian Pacific Journal of Reproduction (APJR) and reviewer of the most important fetal maternal journals. He is in the Speciality and Advisor Editorial Board of webmed central. He is commentator for the Evidence Based Medicine Journal (EBM)

He is in the Board of the Italian College of Fetal Maternal Medicine and in the board of the Italian Society of Echocardiography. He is the Scientific Director for "Computerized Screening of fetal Aneuploidies" (SCA-test)programme. He is Scientific research Director at ARTEMISIA Fetal Maternal Medical Centre in Rome, ITALY

Italian College of Fetal Maternal Medicine

The Italian College of Fetal Maternal Medicine is a scientific, cultural, didactic and educational company which combines the scientific, professional and clinical interests of a number of experts in the obstetrical, prenatal and perinatal field with the purpose of promoting and encouraging, in every possible way, clinical, educational and researching activity and to be representative both at national and international level, in the clinical environment of obstetrics, invasive prenatal diagnosis, biochemical and biophysical research methodologies in pregnancy, ultrasound and in

general the whole fertility medicine of the mother and the foetus. The company’s proposal is to

give stimulus to clinical studies and researches in the following fields:

I) Prenatal diagnosis in every form and aspect (from laboratories aspects to invasive

manoeuvers). II) Fetal Ultrasound III) Cure and surgery of the pregnant woman and the foetus.

IV) Reduced capacity of pregnancy of women (especially referring to fertility, implantation,

abortion). V) Maternal physiology and pathology (especially referring to every kind of complications in pregnancy). VI) Screening programs in prenatal diagnosis and foetal medicine. VII) Clinical and standard research of foetal and maternal-foetal pathology. VIII) Clinical and standard genetic applied to prenatal diagnosis. IX) Medical and legal aspects regarding prenatal diagnosis of the mother and the foetus.

The principal aims are:

• promoting and supporting of the educational and didactic activity; • promoting of research in the specific environment; • guardianship of the members of the company regarding every normative, professional and

economic issue.

• In the year 2013 several editions of education courses addressed to health professionals, with

special regards for Specialists in obstetrics and gynecology are scheduled.

Very next courses:

• Apr.18th (past editions: Jan.17th – Feb.21st – Mar.14th): Professional Training for the • Computerized Aneuploidies Screening. • May23rd: The early anomaly Scan. • Jun.19th: Doppler in Fetal Maternal Medicine.

In particular, the IV National Congress of the Italian College of Fetal Maternal Medicine is going to

be held in Rome from Dec.13th to Dec.15th under the following heading “Fetal ultrasound and

prenatal diagnosis: national legislation. Comprehension and applicability of the first guidelines

written by the Ministry of Health” presided by Prof. Giorlandino. Also scheduled is an additional

symposium “Course of breast disease diagnostics” held by Prof. Dolfin.

6. How to use European Funds for Bilateral and International Cooperation Roberto MORINILLI, CEO Gaia Italy, Torino, Italy

GAIA Italy - PARTNER for CONSULTING

Guide for the Achievement of Industrial Audit-system

The COMPANY

GAIA ITALY S.r.l. was born on July 2004 from the union of multi annual experiences in the different operating fields of the company.

Our procedure: high skilled local personnel for the accomplishment of different activities in which it is involved. That’s the reason why we operate in different areas only after a deep and careful search for local collaborators able to maintain the quality standards of our services. The local human resources bring with attention and respect of the local culture, a prompt intervention in urgent conditions, and an enrichment of the territory by a continuous increase of high qualified professional figures and consequent added value.

Top management constantly supervises all staff co-operators activities, granting to customers the highest reliability level and a quick intervention in case of need, concretely reaching all the shared objectives.

Our distinguishing marks: sustainable entrepreneurship, integrity, team work, exploitation of skills and differences, results guidance, value creation for customers.

FIELDS OF ACTIVITIES IN SHORT

Internationalization processes & Competitiveness Strategies

Together with the organizations we pursue a constant development and improvement in order that they reach and maintain a solid presence on the market with their own competitiveness characteristics.

The global market produces a nearly unlimited number of “competitors”: the strategic choices necessary for survival, stabilization and development have to put the organizations in the condition to measure and to compare themselves with potential and real competitors. Consulting intervention aims at providing the organizations with the

capability to face both the close market and the global one by using their own strategies and the opportunities offered by their internal structures.

Consulting operative elements can be resumed in the following phases:

1) Check up and/or SWOT Analysis 2) Elaboration and definition of the evolutionary meta-model 3) Identification of: • trade opportunities; markets needs; market trends • markets of reference for trade exchanges development • market driving forces • actors and stakeholders to involve in the process 4) Definition of a shared Action Plan for opening trade exchanges channels 5) Development of the shared Action Plan; some potential main activities: • Management of the relations with the local authorities, actors and stakeholders selected and involved • Promotion and adoption of standardization processes for the actors/stakeholders involved through the adoption of International Protocols and according to international standards (ISO, BSI, …) • Complying with the local legislation (environment, safety, privacy, etc.)

Sustainable development

Our consulting intervention aims at giving to the public administration, responsible for the Territory, a cognitive support and know-how for making useful choices within the framework of sustainable development pursuance; this for preserving Its ecosystem provided with resources in which nature (flora and fauna) and human settlements need to live together in harmony.

This solution is possible thanks to the use of evolutionary models, able to put in evidence the Territorial evolution when the referring indicators, typical of the territory itself, change. GAIA ITALY developed this innovative methodological instrument aiming at measuring and visualizing the future impacts deriving from today’s choices. The target of this service is to set up and to carry out a Sustainable Action Plan in which the local authorities define a specific programme for obtaining objectives for a sustainable growing of the pertinent territory coherent with the local priorities and economic sectors.

Orienting strategies for SMEs Associations

The need of SMEs Associations to be oriented

in interpreting the associates’ needs

• in making them concrete within the framework of a market constantly in evolution and under the pressure of changes,

• in being efficacious in carrying out their statutory actions • in defining needs in training activities for its associates. Training often

represents a difficulty in finding both time and financial resources and, in consideration of this the access to unsecured funds financing training courses can make the difference. In this case we operate for:

o preparing, managing and coordinating the applications o designing and managing training courses

• the Institutional relations that help the Associations to penetrate and to move easily in the inside of Foreign Territories they look at for their development.

In such contest, we intervene for favoring the establishment and development of necessary understandings and consequent actions with competent National/Local Authorities for the definition of “shared way” in the interest of actors and stakeholders involved.

National, EU, World Bank Funding Programmes

• organization of the processes to support Private and Public Entities (from European & Extra European Countries) in applying for funds made available by National/Regional Authorities, the European Union and other International Organization in support of “Research and Technological Development”, “Competitiveness and Innovation”, “Sustainable Development”, “Cooperation”

• coordination and support to the implementation of technical, financial and administrative/bureaucratic activities of financed projects. This experience has been developed to cope with the increasing needs of Public and Private Entities to find financial resources for their development and innovation investments: funds represent, in fact, a possible way for giving a concrete reply to such needs.

Our approach is concretely based on the “partnership principle” through which we share, with Public and Private Entities of our Network, the way along which:

• identifying needs to satisfy • sizing the funding opportunities • identifying the most feasible and sustainable funding opportunities • selecting, putting together and managing partners of excellence for their

involvement in the appropriate applications • applying for funds identified.

For any other info: www.gaiaitaly.com.

Abstract HOW FOR USING EU FOUNDS?

A short presentation by GAIA Italy about the new program HORIZON 2020 that might open good opportunityin R&D

Horizon 2020 program changes radically from the past, bigger founds, higher partnership, lower number of projects more addressed to specific aims.

For this GAIA Italy propose:

To define the real common interests and goals of thepresent in this summit, that need of financial supports

To create a continue Council to define program and increase the group of participants for presenting call for proposals;

Topromotea concrete lobby in Bruxelles to develop knowledge and interest of EU Commission about ITC Health (telemedicine), for a new health care prevention.

To pursue any way to present our proposals to EU Commission because they become items for calls for proposal.

To hear and consult continuously EU offices to understand at the best the rules that the Commission will adopt to launch the new calls for proposal.

To prepare a defined program to participate at calls for proposal.

That means to organize and to be organized.

GAIA Italy purposes its own to support the associations to reach EU founds.

Found Benefits for EU citizens Benefit

7. Real World Developments in providing Education and Training to Doctors Ram Dhillon, Clinical Director, RILA INSTITUTE OF HEALTH SCIENCES, LONDON, UK

(Online blended postgraduate medical training and qualifications)

Biography

Professor Ram Dhillon FRCS, is a consultant ENT surgeon with the North West London Hospitals NHS Trust and Honorary Professor, School of Medical & Social Sciences, Middlesex University, London. With over 30 years experience as an ENT and Head & Neck Specialist, he has actively pursued his clinical career and has special interests in sinofacial pain and voice disorders.

His other major interest is in medical education and he has developed numerous nationally-accredited initiatives to improve the delivery of patient care. These include postgraduate medical courses for GPs and Nurses (Diabetes, Cardiology, ENT, Ophthalmology, Medicine in the Older Person, Minor Surgery etc), interactive seminars, and eLearning. He edits the “Clinical Focus-Primary Care”, which is the official publication of the APWSI. He lectures and presents regularly to PCTs, PBCs, GPs and other organisations such as the “National Association for Primary Care”.

Principal post: Consultant Surgeon, Northwick Park Hospital

Qualification: Middlesex Hospital Medical School (now UCL), London, 1978

Special Interests: ENT, Minor Surgery and medical education

Specialist experience: accredited ENT surgeon

Examining & Teaching experience: Examiner and teacher on Diplomas for ENT & Minor Surgery

National profile: Has championed the development of GPs and Nurses with Special Interests

Rila headquartered in London, UK, ranks among the largest and fastest growing providers of continuing professional education for medical practitioners in the UK and Europe.

Rila has a sustained and strong heritage over 20 years in the provision of medical and healthcare education and related services.

Rila has pioneered online teaching and assessment and private/university collaboration in delivering education to healthcare professionals. .

Abstract

It has become increasingly apparent that the greatest benefit to the health of a population, and the most cost effective, is if care can be delivered in the community/primary care sector. Secondary care is very expensive. The traditional methods of teaching require major resource input, take doctors out of their normal work duties and disrupt social and personal life. All these various factors has led to fewer doctors skilled to the level that is required to deliver care, with many being trained to deliver the high end complex care required in the secondary sector. There is a mismatch of what is required and what is being delivered and where it is delivered. Rila Institute of Health Sciences has developed, in collaboration with Middlesex University, London, a series of medical postgraduate programmes to enhance the knowledge and skills of doctors from a basic to an intermediate tier level. This would equip qualified doctors to deliver health care in the community but also practice to middle grade seniority in the hospital sector. This level of expertise can be delivered and attained over a 12 month period and then formally assessed and a Postgraduate qualification awarded by the University (120 level 7 Masters credits). The Rila qualifications also have recognition from the Royal College of General Practitioners (UK) and the National Association of Primary Care (UK). The clinical areas available to the Postgraduate Diploma level include Cardiology, Diabetes, Urology, Family Medicine, ENT, Ophthalmology, Musculoskeletal Medicine, Dermatology and Ophthalmology. There are shorter programmes in Stroke Medicine and key aspects of Minor Surgery. The learning is delivered in a BLENDED form consisting of some face to face workshops and specifically created online activity. The online components are commissioned reading, with interactive elements coupled with online instant feedback assessments. Additionally, there are timed clinical case scenarios requiring the application of knowledge and skills to reproduce real time clinical activity. Rila have also created an online discussion forum to enable interaction between participants with a specialist clinical facilitator, which is a virtual clinical teaching ward round. Furthermore, a specific module, in each specialty programme, is dedicated to the core “Clinical and Diagnostic” requirements within that clinical specialty. There is a final summative examination. Rila have managed to use technology to extend the participation of doctors in postgraduate training, enhance the number of intermediate tier care specialists and ultimately have a positive impact on healthcare delivered to the patient, particularly in the community setting. Rila launched these clinical programmes in the UK in 1998. It has also created local hubs in the Middle East (Sharjah) and India (Chennai and Delhi). The EU, in which healthcare is a priority, could consider this model as a mechanism for fast track postgraduate medical training.

8. Gabor VICZE, Econet Open Funding Kft, Budapest, Hungary Innovation models to transfer knowledge into business

Abstract Most important trend of recent years in the world of innovation is the emergence of Open Innovation model (based on Chesborough model). At the same time venture financing and lean start-up methodology are more and more popular. The showcase for these models is the Silicon Valley, where infocommunication start-ups are using these models a lot. This is typically characterized by very fast development cycles, through the internet huge upscaling potential.This model is emerging in Europe too as European Commission and national governments provide a number of start-up programs and public funding. At the same time first successful internet entrepreneurs started to act as angel investors and promoting these models heavily, opened incubation / acceleration programs throughout Europe. On top of this European Commission will open Horizon 2020 program next year to boost R&D activity in Europe.We have already identified a few models how to make the most of the infocomm startups models also in other industries. Key part of the solution is to move away from the resource consuming consulting model, use shorter development cycles and test the product as soon as possible on the market.Even more relevant is to make an on-line inventory of the innovation actors and help them to network and combine their expertise – also to support them defining attractive business cases for private investors.These type of on-line innovation agency models have been already implemented in some regions (example Spain) and a recent project supported by European Commission aims to benchmark European accelerator programs, create a best practice accelerator and support 60 European startups.

Galina Sklyarova, PhD

Associate Project Manager

WEIL Foundation

Biography

1997-1999 Sport Military College, Almaty, Kazakhstan

1997-2001National Academy of Sport and Tourism, majoring

in physical education teaching and couching, Almaty, Kazakhstan

2010-2012 Assistant Project Manager Space for Earth Foundation

for International Russia Relationships

Expert in Medical Tourism, International Events Management and Luxury Couture

Managing Director JTF – Just Technology for Fashion, International Fashion

Couture Company.

WABT Associate Project Manager on International Relationships with Russia

and Former Soviet Republics.

Managing Coordinator WEIL Foundation Events, Masters and Courses

Associate Managing Director HealthLife Creative Enterprise Ltd, London, UK

WEIL Foundation

WABT European Institute for Life (EIfl or EIL or WEIL) is an International Company of Public Interest, addressing Medicine of Life, founded and registered in Budapest, Hungary in 2010.

Medicine of Life is defined as a new medical discipline that links on inter-operability bases Male and Female Fertility, Human Reproduction and Embryos Development. This Clinical and BioMedical Field is at the core of the Health Gate for the Ethics, International Rights and Laws, Innovation Technologies and BioTechnologies for Human Applications through BioInformatics, Genetics, Germ Stem Cells Research and Therapy and represents the strategic core for Human Wellbeing and Quality of Life.

In December 2010, WABT promoted The First International Meeting on Medicine of Life MED-LIFE 2010 under the aegis of the 14th WABT General Conference with the support of Hungarian institutions and partners and with the sustain of CIRIS International, to launch WEIL Foundation.

The aim of the Conference was to debate of Main Topics: Germ Stem Cells, Male Fertility Factor, Testicular Biopsy, Meiosis and Spermatogenesis, Microsurgery of Male Infertility, BioTechnologies in Human Reproduction, IMSI Technique, Innovation Technologies in Male Reproduction, The Sperm Laboratory, Infrared Technologies. The Strategy of the Conference was centered on the new technological and biotechnological advances in Male Fertility and Microsurgery with the Ethical and Legal Aspects of Sperm Selection for IMSI and Embryos Development. An international panel of world-wide distinguished speakers illustrated the advantages of the new technical, medical and microsurgical approaches and their impact on a responsable reproduction; the international expertsalso met representatives of the civil society in an „open door” round table on the value of a new Quality of Life Medicine in Human Reproduction. The Conference was opened to pre- and post-graduated students in biomedical field and related disciplines.

The project of the Foundation Institute for Life - IfL, promoted by WABT, was presented to the invited guests and to the communication media by the CEOs of the European Institute for Life (EIfL non profit Ltd), as an international non-for profit company of public interest.